2,815
Views
7
CrossRef citations to date
0
Altmetric
Article

Gynecologists are afraid of prescribing hormone replacement to endometrial/ovarian cancer survivors despite national guidelines—a survey in Sweden

, &
Pages 225-229 | Received 10 Oct 2018, Accepted 01 Nov 2018, Published online: 10 Dec 2018

Figures & data

Table 1. Characteristics of the respondents.

Figure 1. Percentage of gynecologic oncologists (blue) and gynecologists (red) who agree/strongly agree that estrogen replacement therapy (ERT) is contraindicated (no ERT), prescribe systemic ERT or local estrogen therapy. Non-significant differences between gynecologic oncologists and gynecologists (Fisher’s exact test).

Figure 1. Percentage of gynecologic oncologists (blue) and gynecologists (red) who agree/strongly agree that estrogen replacement therapy (ERT) is contraindicated (no ERT), prescribe systemic ERT or local estrogen therapy. Non-significant differences between gynecologic oncologists and gynecologists (Fisher’s exact test).

Figure 2. Percentage of gynecologic oncologists (blue) and gynecologists (red) who agree/strongly agree that estrogen replacement therapy (ERT) is contraindicated (no ERT) and drug of choice in the high-risk endometrial case. *p = 0.039; **p = 0.011 (Fisher’s exact test).

Figure 2. Percentage of gynecologic oncologists (blue) and gynecologists (red) who agree/strongly agree that estrogen replacement therapy (ERT) is contraindicated (no ERT) and drug of choice in the high-risk endometrial case. *p = 0.039; **p = 0.011 (Fisher’s exact test).

Table 2. Comparison of prescription intentions between Swedish, Japanese, and German doctors.